| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Other expense, net | -3,497 | -2,701 | -1,431 | -2,889 |
| Income before income taxes | 47,515 | 40,097 | 33,450 | 36,749 |
| Provision for income taxes | 11,087 | 5,878 | 6,546 | 840 |
| Net income | 36,428 | 34,219 | 26,904 | 35,909 |
| Basic (in shares) | 238,602,978 | 241,490,715 | 237,775,476 | 234,571,376 |
| Basic earnings per common share (in dollars per share) | 0.15 | 0.14 | 0.11 | 0.15 |
| Diluted (in shares) | 244,664,263 | 248,608,460 | 244,676,350 | 244,804,065 |
| Diluted earnings per common share (in dollars per share) | 0.15 | 0.14 | 0.11 | 0.15 |
ADMA BIOLOGICS, INC. (ADMA)
ADMA BIOLOGICS, INC. (ADMA)